References
- Holt JA, Luo G, Billin AN, et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 2003;17(13):1581–1591.
- Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2(4):217–225.
- Kong B, Wang L, Chiang JY, et al. Mechanism of tissue-specific farnesoid x receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology. 2012;56(3):1034–1043.
- Lenicek M, Duricova D, Komarek V, et al. Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflamm Bowel Dis. 2011;17(6):1322–1327.
- Alisi A, Ceccarelli S, Panera N, et al. Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease. PLoS One. 2013;8(6):e67160.
- Mutanen A, Lohi J, Heikkilä P, et al. Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure. J Hepatol. 2015;62(6):1391–1397.
- Arab JP, Karpen SJ, Dawson PA, et al. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology. 2017;65(1):350–362.
- Xiao YT, Cao Y, Zhou KJ, et al. Altered systemic bile acid homeostasis contributes to liver disease in pediatric patients with intestinal failure. Sci Rep. 2016;6:39264.
- Luo J, Ko B, Elliott M, et al. A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Sci Transl Med. 2014;6(247):247ra100.
- Zhou M, Learned RM, Rossi SJ, et al. Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice. Hepatology. 2016;63(3):914–929.
- Modica S, Petruzzelli M, Bellafante E, et al. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology. 2012;142(2):355–65.e1.
- Zaloga GP. Phytosterols, lipid administration, and liver disease during parenteral nutrition. J Parenter Enter Nutr. 2015;39(1 Suppl):39S–60S.
- Grijalva J, Vakili K. Neonatal liver physiology. Semin Pediatr Surg. 2013;22(4):185–189.
- Gavaldà-Navarro A, Pastor JJ, Mereu A, et al. Developmental regulation of the intestinal FGF19 system in domestic pigs. Am J Physiol Gastrointest Liver Physiol. 2018;314(6):G647–G654.
- Sánchez-Infantes D, Gallego-Escuredo JM, Díaz M, et al. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations. Int J Obes. 2015;39(5):742–746.
- Gälman C, Arvidsson I, Angelin B, et al. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. J Lipid Res. 2003;44(4):859–866.
- Camilleri M, Nadeau A, Tremaine WJ, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009;21(7):734–e43.
- Burke KT, Horn PS, Tso P, et al. Hepatic bile acid metabolism in the neonatal hamster: expansion of the bile acid pool parallels increased Cyp7a1 expression levels. Am J Physiol Gastrointest Liver Physiol. 2009;297(1):G144–G151.
- Cuesta de Juan S, Monte MJ, Macias RI, et al. Ontogenic development-associated changes in the expression of genes involved in rat bile acid homeostasis. J Lipid Res. 2007;48(6):1362–1370.
- Lewis DS, Oren S, Wang X, et al. Developmental changes in cholesterol 7alpha- and 27-hydroxylases in the piglet. J Anim Sci. 2000;78(4):943–951.
- Massimi M, Lear SR, Huling SL, et al. Cholesterol 7alpha-hydroxylase (CYP7A): patterns of messenger RNA expression during rat liver development. Hepatology. 1998;28(4):1064–1072.
- Norlin M. Expression of key enzymes in bile acid biosynthesis during development: CYP7B1-mediated activities show tissue-specific differences. J Lipid Res. 2002;43(5):721–731.
- Back P, Walter K. Developmental pattern of bile acid metabolism as revealed by bile acid analysis of meconium. Gastroenterology. 1980;78(4):671–676.
- Kimura A, Suzuki M, Murai T, et al. Perinatal bile acid metabolism: analysis of urinary bile acids in pregnant women and newborns. J Lipid Res. 1997;38(10):1954–1962.
- Kumagai M, Kimura A, Takei H, et al. Perinatal bile acid metabolism: bile acid analysis of meconium of preterm and full-term infants. J Gastroenterol. 2007;42(11):904–910.
- Nakagawa M, Setchell KD. Bile acid metabolism in early life: studies of amniotic fluid. J Lipid Res. 1990;31(6):1089–1098.
- Lundåsen T, Gälman C, Angelin B, et al. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med. 2006;260(6):530–536.
- Vincentz JW, McWhirter JR, Murre C, et al. FGF15 is required for proper morphogenesis of the mouse cardiac outflow tract. Genesis. 2005;41(4):192–201.
- Xie MH, Holcomb I, Deuel B, et al. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine. 1999;11(10):729–735.
- Nishimura T, Utsunomiya Y, Hoshikawa M, et al. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta. 1999;1444(1):148–151.